Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...

Budget documents for Congress provide the most detailed look yet at how the Trump Administration hopes to reshape the ...

AstraZeneca CEO Pascal Soriot views the company's stock price — up just 10% year-to-date — as a marker of how he is doing. He ...

An exercise program can reduce the risk that colorectal cancer will return after surgery and chemotherapy, according to a new ...

This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more ...

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

Amid ongoing uncertainty around funding for the NIH and what it could mean for U.S. innovation, a top Merck executive ...

The use of Gilead’s Trodelvy and Merck’s Keytruda together could be practice-changing based on the results of a new study ...

The annual meeting of the American Society of Clinical Oncology is the most visible showcase for new cancer drug data. Join industry leaders, scientific experts, and STAT reporters for an ...

After five busy days surfing cancer studies in the Windy City, STAT’s team of reporters will take the virtual stage to distill key scientific breakthroughs, gather business intelligence, and ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...